Kala Bio (KALA) Invested Capital (2016 - 2025)
Kala Bio's Invested Capital was $19.75 million in Q3 2025, down 53.0% from $42 million a year earlier and down 21.3% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Invested Capital (2016 - 2025) Analysis & Trends
For FY2024, Invested Capital at Kala Bio came in at $42.77 million, up 2.6% from FY2023.
- Invested Capital shows a five-year compound annual growth rate of -15.8% (FY2019 to FY2024).
- In earlier years, Invested Capital was $41.69 million in FY2023 (-32.7%), $61.91 million in FY2022 (-35.3%), $95.73 million in FY2021 (-44.4%) and $172.24 million in FY2020 (+70.7%).
- The Q3 2025 figure marks the lowest quarterly Invested Capital since Q2 2017.
- Compared with a year earlier, Invested Capital has declined for three straight quarters, with an average decline of 22.8% over the last eight quarters.
- The best year-over-year quarter for Invested Capital over five years was Q4 2020 (growth of 70.7%); the worst was Q2 2022 (a decline of 70.3%).
- Per Business Quant data, KALA's Invested Capital in the three quarters before Q3 2025 was $25.09 million (Q2 2025), $36.33 million (Q1 2025) and $42.77 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Kala Bio | 6.57 Mn | 6.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 19.75 Mn |
| Jun 30, 2025 | 25.09 Mn |
| Mar 31, 2025 | 36.33 Mn |
| Dec 31, 2024 | 42.77 Mn |
| Sep 30, 2024 | 42.00 Mn |
| Jun 30, 2024 | 48.53 Mn |
| Mar 31, 2024 | 41.16 Mn |
| Dec 31, 2023 | 41.69 Mn |
| Sep 30, 2023 | 45.10 Mn |
| Jun 30, 2023 | 51.06 Mn |
| Mar 31, 2023 | 56.73 Mn |
| Dec 31, 2022 | 61.91 Mn |
| Sep 30, 2022 | 41.67 Mn |
| Jun 30, 2022 | 48.25 Mn |
| Mar 31, 2022 | 74.08 Mn |
| Dec 31, 2021 | 95.73 Mn |
| Sep 30, 2021 | 139.96 Mn |
| Jun 30, 2021 | 162.33 Mn |
| Mar 31, 2021 | 182.31 Mn |
| Dec 31, 2020 | 172.24 Mn |
API Access
Kala Bio Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();